Erdafitinib (ERDA) vs ERDA plus cetrelimab (ERDA plus CET) for patients (pts) with metastatic urothelial carcinoma (mUC) and fibroblast growth factor receptor alterations (FGFRa): Final results from the phase 2 Norse study.

Siefker-Radtke A. O., Powles T., Moreno V., Kang T. W., Cicin I., Girvin A., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.41, sa.16_SUPPL, 2023 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 41 Sayı: 16_SUPPL
• Basım Tarihi: 2023
• Doi Numarası: 10.1200/jco.2023.41.16_suppl.4504
• Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database, Nature Index
• Trakya Üniversitesi Adresli: Evet